The UK’s biotech sector plays a pivotal role in delivering breakthrough healthcare solutions, from next-generation therapeutics to synthetic biology and precision diagnostics. To accelerate innovation in this high-risk, high-reward field, the government offers a range of biotech grants and R&D tax relief opportunities.
FI Group supports biotech firms across the full funding landscape — from securing innovation grants to maximising R&D tax credits. Our PhD-level consultants combine scientific insight with technical tax expertise to help companies navigate the complexities of biotech funding in the UK.
The life sciences sector is defined by continuous research and experimentation. Common areas of qualifying R&D activity include:
If your project seeks to resolve scientific or technological uncertainties and involves systematic investigation, it is likely to qualify under HMRC’s R&D criteria.
